You are currently viewing a new version of our website. To view the old version click .
by
  • Rachel A. Chiaverelli1,2,
  • Kang-Quan Hu1 and
  • Chun Liu1
  • et al.

Reviewer 1: Wael Mahdi Reviewer 2: John W. Erdman

Round 1

Reviewer 1 Report

1. how the animals were treated with the test samples.

2. what is the rartionale of this study.

3. the important findings must be updated. 

Author Response

Reviewer 1:

  1. How the animals were treated with the test samples.

Response: Thank you. We have added “The supplementation of BCX at 20 mg/kg diet was given daily to the mice starting two-weeks prior to the CS-exposure and continued for 2 weeks during the CS-exposure”. Please see the method section, line 396-398, in the revised manuscript.

  1. What is the rationale of this study.

Response: Thank you. We have outlined more clearly the rationale of this study (see line 84-87 and line 94-99). Specifically, we aimed to understand whether carotenoid cleavage enzymes (BCO1/BCO2 genotype) modify the effects of BCX supplementation in smokers, and to further understand whether the effect of BCX is a result of the actions of BCX or its enzymatic cleavage metabolites (see line 100 to 104)

  1. The important findings must be updated. 

Response: We have indicated the important findings in both the graphic abstract and in the manuscript (line 261-271). In the revised manuscript, we have highlighted further that the effect of BCX could be a result of the actions of BCX rather than its enzymatic cleavage metabolites of BCO1/BCO2 (see line 272).  

Author Response File: Author Response.pdf

Reviewer 2 Report

This is a very carefully prepared and described in vivo and in vitro study of the impact of BCX on cigarette smoke-induced lung lesions.  It follows up on the prior work from this group.  There are only a few suggestion/questions.

1. Table 1.  It is not clear why there are two control groups within WT mice listed in the table.  Please clarify.

2.  Lines 135 - 136.  The authors should provide the limit of detection for apo-10'-carotenoids

3. Line 195.  Spelling typo "lowered"

4.  Lines 358 - 360.  Please reword sentence - missing a word. 

Author Response

Reviewer 2:

This is a very carefully prepared and described in vivo and in vitro study of the impact of BCX on cigarette smoke-induced lung lesions.  It follows up on the prior work from this group.  There are only a few suggestion/questions.

  1. Table 1.  It is not clear why there are two control groups within WT mice listed in the table.  Please clarify.

Response: Thank you for your thorough review. We believe that in Table 1 of the original version the line under wild type was somehow extended to the control group in BCO1/BCO2 DKO mice. . We had only one control group in WT and DKO, respectively. We corrected this in the revised Table 1 and apologize for the confusion

  1. Lines 135 - 136.  The authors should provide the limit of detection for apo-10'-carotenoids

Response: Agreed. The limit of detection for apo-10'-carotenoids in our HPLC system was 10 pmol. We have added the information in line 140

  1. Line 195.  Spelling typo "lowed" Response: agreed and corrected.
  2. Lines 358 - 360.  Please reword sentence - missing a word. Response: agreed and corrected.

Author Response File: Author Response.pdf